Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

The Joint Corp (JYNT)

The Joint Corp (JYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Joint Corp. Reports 2025 Fourth Quarter and Full Year Financial Results

- Fourth Quarter Revenues Increase 3.1% Year over Year -  - Full Year Revenues of $54.9 Million, Net Income of $2.9 Million and a 13.9% Increase in Adjusted EBITDA to $13.0 Million - SCOTTSDALE,...

JYNT : 8.85 (+3.51%)
The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast

SCOTTSDALE, Ariz., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic ®  network, announced it will...

JYNT : 8.85 (+3.51%)
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience

SCOTTSDALE, Ariz., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, appointed Ron Stilwell...

JYNT : 8.85 (+3.51%)
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

SCOTTSDALE, Ariz., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, signed an Asset Purchase...

JYNT : 8.85 (+3.51%)
Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals"

SCOTTSDALE, Ariz. , Nov. 17, 2025 /PRNewswire/ -- The holidays can feel like a full-contact sport for your back. Gift bags, decorations, family gatherings and endless to-do lists all add up, and...

JYNT : 8.85 (+3.51%)
The Joint Corp. Reports Third Quarter 2025 Financial Results

- Grew Revenue 6%, Compared to Third Quarter 2024 -  - Board Authorizes an Additional $12 Million for Share Repurchases - SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Joint Corp....

JYNT : 8.85 (+3.51%)
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program

SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced that its...

JYNT : 8.85 (+3.51%)
The Joint Corp. to Host Conference Call on Thursday, November 6th to Discuss Third Quarter 2025 Results

SCOTTSDALE, Ariz., Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report...

JYNT : 8.85 (+3.51%)
Joint Amends Credit Agreement with JPMorgan Chase

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Joint ( (JYNT)...

JYNT : 8.85 (+3.51%)
The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List

SCOTTSDALE, Ariz. , Oct. 7, 2025 /PRNewswire/ --  The Joint Corp . (NASDAQ: JYNT), the nation's largest provider of chiropractic care through  The Joint Chiropractic ® network, has been...

JYNT : 8.85 (+3.51%)

Barchart Exclusives

This Dividend King Is Down 26%. When Will It Bounce Back?
Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion, the Dividend King seems discounted, but the question is, can it rebound? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.